nodes	percent_of_prediction	percent_of_DWPC	metapath
Plerixafor—Flatulence—Auranofin—psoriatic arthritis	0.0179	0.0179	CcSEcCtD
Plerixafor—Dyspepsia—Auranofin—psoriatic arthritis	0.013	0.013	CcSEcCtD
Plerixafor—Constipation—Auranofin—psoriatic arthritis	0.0127	0.0127	CcSEcCtD
Plerixafor—Inflammation—Methylprednisolone—psoriatic arthritis	0.0125	0.0125	CcSEcCtD
Plerixafor—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.0121	0.0121	CcSEcCtD
Plerixafor—Urticaria—Auranofin—psoriatic arthritis	0.0118	0.0118	CcSEcCtD
Plerixafor—Abdominal pain—Auranofin—psoriatic arthritis	0.0117	0.0117	CcSEcCtD
Plerixafor—Pruritus—Auranofin—psoriatic arthritis	0.0105	0.0105	CcSEcCtD
Plerixafor—Diarrhoea—Auranofin—psoriatic arthritis	0.0101	0.0101	CcSEcCtD
Plerixafor—Vomiting—Auranofin—psoriatic arthritis	0.00942	0.00942	CcSEcCtD
Plerixafor—Rash—Auranofin—psoriatic arthritis	0.00934	0.00934	CcSEcCtD
Plerixafor—Dermatitis—Auranofin—psoriatic arthritis	0.00933	0.00933	CcSEcCtD
Plerixafor—Nausea—Auranofin—psoriatic arthritis	0.0088	0.0088	CcSEcCtD
Plerixafor—Abdominal distension—Prednisolone—psoriatic arthritis	0.00836	0.00836	CcSEcCtD
Plerixafor—Inflammation—Methotrexate—psoriatic arthritis	0.00829	0.00829	CcSEcCtD
Plerixafor—Abdominal distension—Triamcinolone—psoriatic arthritis	0.00769	0.00769	CcSEcCtD
Plerixafor—Abdominal distension—Methylprednisolone—psoriatic arthritis	0.00767	0.00767	CcSEcCtD
Plerixafor—Haemoglobin—Prednisolone—psoriatic arthritis	0.00668	0.00668	CcSEcCtD
Plerixafor—Haemorrhage—Prednisolone—psoriatic arthritis	0.00665	0.00665	CcSEcCtD
Plerixafor—Haemoglobin—Triamcinolone—psoriatic arthritis	0.00614	0.00614	CcSEcCtD
Plerixafor—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.00613	0.00613	CcSEcCtD
Plerixafor—Haemorrhage—Triamcinolone—psoriatic arthritis	0.00611	0.00611	CcSEcCtD
Plerixafor—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.0061	0.0061	CcSEcCtD
Plerixafor—Abdominal distension—Prednisone—psoriatic arthritis	0.00608	0.00608	CcSEcCtD
Plerixafor—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.00599	0.00599	CcSEcCtD
Plerixafor—Erythema—Prednisolone—psoriatic arthritis	0.00579	0.00579	CcSEcCtD
Plerixafor—Haemoglobin—Dexamethasone—psoriatic arthritis	0.00557	0.00557	CcSEcCtD
Plerixafor—Haemoglobin—Betamethasone—psoriatic arthritis	0.00557	0.00557	CcSEcCtD
Plerixafor—Haemorrhage—Dexamethasone—psoriatic arthritis	0.00555	0.00555	CcSEcCtD
Plerixafor—Haemorrhage—Betamethasone—psoriatic arthritis	0.00555	0.00555	CcSEcCtD
Plerixafor—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00551	0.00551	CcSEcCtD
Plerixafor—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.00537	0.00537	CcSEcCtD
Plerixafor—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00534	0.00534	CcSEcCtD
Plerixafor—Erythema—Triamcinolone—psoriatic arthritis	0.00532	0.00532	CcSEcCtD
Plerixafor—Erythema—Methylprednisolone—psoriatic arthritis	0.00531	0.00531	CcSEcCtD
Plerixafor—Malaise—Prednisolone—psoriatic arthritis	0.00522	0.00522	CcSEcCtD
Plerixafor—Syncope—Prednisolone—psoriatic arthritis	0.00519	0.00519	CcSEcCtD
Plerixafor—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00509	0.00509	CcSEcCtD
Plerixafor—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00494	0.00494	CcSEcCtD
Plerixafor—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.00493	0.00493	CcSEcCtD
Plerixafor—Discomfort—Prednisolone—psoriatic arthritis	0.00487	0.00487	CcSEcCtD
Plerixafor—Haemoglobin—Prednisone—psoriatic arthritis	0.00485	0.00485	CcSEcCtD
Plerixafor—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.00483	0.00483	CcSEcCtD
Plerixafor—Haemorrhage—Prednisone—psoriatic arthritis	0.00483	0.00483	CcSEcCtD
Plerixafor—Erythema—Betamethasone—psoriatic arthritis	0.00483	0.00483	CcSEcCtD
Plerixafor—Erythema—Dexamethasone—psoriatic arthritis	0.00483	0.00483	CcSEcCtD
Plerixafor—Malaise—Triamcinolone—psoriatic arthritis	0.0048	0.0048	CcSEcCtD
Plerixafor—Malaise—Methylprednisolone—psoriatic arthritis	0.00479	0.00479	CcSEcCtD
Plerixafor—Syncope—Triamcinolone—psoriatic arthritis	0.00477	0.00477	CcSEcCtD
Plerixafor—Syncope—Methylprednisolone—psoriatic arthritis	0.00476	0.00476	CcSEcCtD
Plerixafor—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00475	0.00475	CcSEcCtD
Plerixafor—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00472	0.00472	CcSEcCtD
Plerixafor—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00468	0.00468	CcSEcCtD
Plerixafor—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00467	0.00467	CcSEcCtD
Plerixafor—Shock—Prednisolone—psoriatic arthritis	0.00465	0.00465	CcSEcCtD
Plerixafor—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00457	0.00457	CcSEcCtD
Plerixafor—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00452	0.00452	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00449	0.00449	CcSEcCtD
Plerixafor—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00448	0.00448	CcSEcCtD
Plerixafor—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00448	0.00448	CcSEcCtD
Plerixafor—Discomfort—Triamcinolone—psoriatic arthritis	0.00448	0.00448	CcSEcCtD
Plerixafor—Discomfort—Methylprednisolone—psoriatic arthritis	0.00447	0.00447	CcSEcCtD
Plerixafor—Dry mouth—Triamcinolone—psoriatic arthritis	0.00443	0.00443	CcSEcCtD
Plerixafor—Immune system disorder—Prednisone—psoriatic arthritis	0.00436	0.00436	CcSEcCtD
Plerixafor—Malaise—Betamethasone—psoriatic arthritis	0.00435	0.00435	CcSEcCtD
Plerixafor—Malaise—Dexamethasone—psoriatic arthritis	0.00435	0.00435	CcSEcCtD
Plerixafor—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00434	0.00434	CcSEcCtD
Plerixafor—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00433	0.00433	CcSEcCtD
Plerixafor—Syncope—Betamethasone—psoriatic arthritis	0.00433	0.00433	CcSEcCtD
Plerixafor—Syncope—Dexamethasone—psoriatic arthritis	0.00433	0.00433	CcSEcCtD
Plerixafor—Shock—Triamcinolone—psoriatic arthritis	0.00427	0.00427	CcSEcCtD
Plerixafor—Insomnia—Prednisolone—psoriatic arthritis	0.00427	0.00427	CcSEcCtD
Plerixafor—Shock—Methylprednisolone—psoriatic arthritis	0.00426	0.00426	CcSEcCtD
Plerixafor—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00425	0.00425	CcSEcCtD
Plerixafor—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00424	0.00424	CcSEcCtD
Plerixafor—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00424	0.00424	CcSEcCtD
Plerixafor—Paraesthesia—Prednisolone—psoriatic arthritis	0.00424	0.00424	CcSEcCtD
Plerixafor—Mental disorder—Prednisone—psoriatic arthritis	0.00423	0.00423	CcSEcCtD
Plerixafor—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00421	0.00421	CcSEcCtD
Plerixafor—Erythema—Prednisone—psoriatic arthritis	0.0042	0.0042	CcSEcCtD
Plerixafor—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.0042	0.0042	CcSEcCtD
Plerixafor—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00419	0.00419	CcSEcCtD
Plerixafor—Discomfort—Betamethasone—psoriatic arthritis	0.00406	0.00406	CcSEcCtD
Plerixafor—Discomfort—Dexamethasone—psoriatic arthritis	0.00406	0.00406	CcSEcCtD
Plerixafor—Haemoglobin—Methotrexate—psoriatic arthritis	0.00406	0.00406	CcSEcCtD
Plerixafor—Pain—Prednisolone—psoriatic arthritis	0.00404	0.00404	CcSEcCtD
Plerixafor—Haemorrhage—Methotrexate—psoriatic arthritis	0.00404	0.00404	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00396	0.00396	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00395	0.00395	CcSEcCtD
Plerixafor—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00394	0.00394	CcSEcCtD
Plerixafor—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00394	0.00394	CcSEcCtD
Plerixafor—Insomnia—Triamcinolone—psoriatic arthritis	0.00393	0.00393	CcSEcCtD
Plerixafor—Insomnia—Methylprednisolone—psoriatic arthritis	0.00392	0.00392	CcSEcCtD
Plerixafor—Ill-defined disorder—Prednisone—psoriatic arthritis	0.0039	0.0039	CcSEcCtD
Plerixafor—Paraesthesia—Triamcinolone—psoriatic arthritis	0.0039	0.0039	CcSEcCtD
Plerixafor—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00389	0.00389	CcSEcCtD
Plerixafor—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00389	0.00389	CcSEcCtD
Plerixafor—Shock—Betamethasone—psoriatic arthritis	0.00388	0.00388	CcSEcCtD
Plerixafor—Shock—Dexamethasone—psoriatic arthritis	0.00388	0.00388	CcSEcCtD
Plerixafor—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00387	0.00387	CcSEcCtD
Plerixafor—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00386	0.00386	CcSEcCtD
Plerixafor—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00386	0.00386	CcSEcCtD
Plerixafor—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00382	0.00382	CcSEcCtD
Plerixafor—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00381	0.00381	CcSEcCtD
Plerixafor—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00381	0.00381	CcSEcCtD
Plerixafor—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00381	0.00381	CcSEcCtD
Plerixafor—Malaise—Prednisone—psoriatic arthritis	0.00379	0.00379	CcSEcCtD
Plerixafor—Syncope—Prednisone—psoriatic arthritis	0.00377	0.00377	CcSEcCtD
Plerixafor—Urticaria—Prednisolone—psoriatic arthritis	0.00375	0.00375	CcSEcCtD
Plerixafor—Fatigue—Triamcinolone—psoriatic arthritis	0.00374	0.00374	CcSEcCtD
Plerixafor—Fatigue—Methylprednisolone—psoriatic arthritis	0.00374	0.00374	CcSEcCtD
Plerixafor—Pain—Triamcinolone—psoriatic arthritis	0.00371	0.00371	CcSEcCtD
Plerixafor—Loss of consciousness—Prednisone—psoriatic arthritis	0.0037	0.0037	CcSEcCtD
Plerixafor—Immune system disorder—Methotrexate—psoriatic arthritis	0.00365	0.00365	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00359	0.00359	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00359	0.00359	CcSEcCtD
Plerixafor—Arthralgia—Prednisone—psoriatic arthritis	0.00358	0.00358	CcSEcCtD
Plerixafor—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00358	0.00358	CcSEcCtD
Plerixafor—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00357	0.00357	CcSEcCtD
Plerixafor—Insomnia—Betamethasone—psoriatic arthritis	0.00356	0.00356	CcSEcCtD
Plerixafor—Insomnia—Dexamethasone—psoriatic arthritis	0.00356	0.00356	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00356	0.00356	CcSEcCtD
Plerixafor—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00354	0.00354	CcSEcCtD
Plerixafor—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00354	0.00354	CcSEcCtD
Plerixafor—Paraesthesia—Betamethasone—psoriatic arthritis	0.00354	0.00354	CcSEcCtD
Plerixafor—Discomfort—Prednisone—psoriatic arthritis	0.00354	0.00354	CcSEcCtD
Plerixafor—Mental disorder—Methotrexate—psoriatic arthritis	0.00354	0.00354	CcSEcCtD
Plerixafor—Erythema—Methotrexate—psoriatic arthritis	0.00351	0.00351	CcSEcCtD
Plerixafor—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00348	0.00348	CcSEcCtD
Plerixafor—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00347	0.00347	CcSEcCtD
Plerixafor—Dyspepsia—Betamethasone—psoriatic arthritis	0.00347	0.00347	CcSEcCtD
Plerixafor—Urticaria—Triamcinolone—psoriatic arthritis	0.00345	0.00345	CcSEcCtD
Plerixafor—Urticaria—Methylprednisolone—psoriatic arthritis	0.00344	0.00344	CcSEcCtD
Plerixafor—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00343	0.00343	CcSEcCtD
Plerixafor—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00343	0.00343	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.0034	0.0034	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.0034	0.0034	CcSEcCtD
Plerixafor—Fatigue—Dexamethasone—psoriatic arthritis	0.0034	0.0034	CcSEcCtD
Plerixafor—Fatigue—Betamethasone—psoriatic arthritis	0.0034	0.0034	CcSEcCtD
Plerixafor—Shock—Prednisone—psoriatic arthritis	0.00338	0.00338	CcSEcCtD
Plerixafor—Pain—Betamethasone—psoriatic arthritis	0.00337	0.00337	CcSEcCtD
Plerixafor—Pain—Dexamethasone—psoriatic arthritis	0.00337	0.00337	CcSEcCtD
Plerixafor—Nervous system disorder—Prednisone—psoriatic arthritis	0.00337	0.00337	CcSEcCtD
Plerixafor—Skin disorder—Prednisone—psoriatic arthritis	0.00333	0.00333	CcSEcCtD
Plerixafor—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00332	0.00332	CcSEcCtD
Plerixafor—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00326	0.00326	CcSEcCtD
Plerixafor—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00325	0.00325	CcSEcCtD
Plerixafor—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00325	0.00325	CcSEcCtD
Plerixafor—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00322	0.00322	CcSEcCtD
Plerixafor—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00322	0.00322	CcSEcCtD
Plerixafor—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.0032	0.0032	CcSEcCtD
Plerixafor—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00319	0.00319	CcSEcCtD
Plerixafor—Malaise—Methotrexate—psoriatic arthritis	0.00317	0.00317	CcSEcCtD
Plerixafor—Urticaria—Betamethasone—psoriatic arthritis	0.00313	0.00313	CcSEcCtD
Plerixafor—Urticaria—Dexamethasone—psoriatic arthritis	0.00313	0.00313	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00313	0.00313	CcSEcCtD
Plerixafor—Dizziness—Prednisolone—psoriatic arthritis	0.00312	0.00312	CcSEcCtD
Plerixafor—Asthenia—Triamcinolone—psoriatic arthritis	0.00312	0.00312	CcSEcCtD
Plerixafor—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00312	0.00312	CcSEcCtD
Plerixafor—Abdominal pain—Betamethasone—psoriatic arthritis	0.00312	0.00312	CcSEcCtD
Plerixafor—Asthenia—Methylprednisolone—psoriatic arthritis	0.00311	0.00311	CcSEcCtD
Plerixafor—Insomnia—Prednisone—psoriatic arthritis	0.0031	0.0031	CcSEcCtD
Plerixafor—Paraesthesia—Prednisone—psoriatic arthritis	0.00308	0.00308	CcSEcCtD
Plerixafor—Pruritus—Triamcinolone—psoriatic arthritis	0.00307	0.00307	CcSEcCtD
Plerixafor—Pruritus—Methylprednisolone—psoriatic arthritis	0.00307	0.00307	CcSEcCtD
Plerixafor—Dyspepsia—Prednisone—psoriatic arthritis	0.00302	0.00302	CcSEcCtD
Plerixafor—Arthralgia—Methotrexate—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Plerixafor—Rash—Prednisolone—psoriatic arthritis	0.00298	0.00298	CcSEcCtD
Plerixafor—Dermatitis—Prednisolone—psoriatic arthritis	0.00297	0.00297	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00297	0.00297	CcSEcCtD
Plerixafor—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00296	0.00296	CcSEcCtD
Plerixafor—Fatigue—Prednisone—psoriatic arthritis	0.00296	0.00296	CcSEcCtD
Plerixafor—Headache—Prednisolone—psoriatic arthritis	0.00296	0.00296	CcSEcCtD
Plerixafor—Discomfort—Methotrexate—psoriatic arthritis	0.00296	0.00296	CcSEcCtD
Plerixafor—Constipation—Prednisone—psoriatic arthritis	0.00293	0.00293	CcSEcCtD
Plerixafor—Dizziness—Triamcinolone—psoriatic arthritis	0.00287	0.00287	CcSEcCtD
Plerixafor—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00287	0.00287	CcSEcCtD
Plerixafor—Dizziness—Methylprednisolone—psoriatic arthritis	0.00287	0.00287	CcSEcCtD
Plerixafor—Feeling abnormal—Prednisone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Plerixafor—Asthenia—Dexamethasone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Plerixafor—Asthenia—Betamethasone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Plerixafor—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00281	0.00281	CcSEcCtD
Plerixafor—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00281	0.00281	CcSEcCtD
Plerixafor—Nausea—Prednisolone—psoriatic arthritis	0.00281	0.00281	CcSEcCtD
Plerixafor—Pruritus—Betamethasone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Plerixafor—Pruritus—Dexamethasone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Plerixafor—Skin disorder—Methotrexate—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Plerixafor—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00277	0.00277	CcSEcCtD
Plerixafor—Vomiting—Triamcinolone—psoriatic arthritis	0.00276	0.00276	CcSEcCtD
Plerixafor—Vomiting—Methylprednisolone—psoriatic arthritis	0.00276	0.00276	CcSEcCtD
Plerixafor—Rash—Triamcinolone—psoriatic arthritis	0.00274	0.00274	CcSEcCtD
Plerixafor—Dermatitis—Triamcinolone—psoriatic arthritis	0.00274	0.00274	CcSEcCtD
Plerixafor—Rash—Methylprednisolone—psoriatic arthritis	0.00273	0.00273	CcSEcCtD
Plerixafor—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00273	0.00273	CcSEcCtD
Plerixafor—Urticaria—Prednisone—psoriatic arthritis	0.00273	0.00273	CcSEcCtD
Plerixafor—Headache—Triamcinolone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Plerixafor—Headache—Methylprednisolone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Plerixafor—Abdominal pain—Prednisone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Plerixafor—Diarrhoea—Dexamethasone—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Plerixafor—Diarrhoea—Betamethasone—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00261	0.00261	CcSEcCtD
Plerixafor—Dizziness—Dexamethasone—psoriatic arthritis	0.00261	0.00261	CcSEcCtD
Plerixafor—Dizziness—Betamethasone—psoriatic arthritis	0.00261	0.00261	CcSEcCtD
Plerixafor—Insomnia—Methotrexate—psoriatic arthritis	0.00259	0.00259	CcSEcCtD
Plerixafor—Nausea—Triamcinolone—psoriatic arthritis	0.00258	0.00258	CcSEcCtD
Plerixafor—Paraesthesia—Methotrexate—psoriatic arthritis	0.00258	0.00258	CcSEcCtD
Plerixafor—Nausea—Methylprednisolone—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Plerixafor—Dyspnoea—Methotrexate—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Plerixafor—Hypersensitivity—Prednisone—psoriatic arthritis	0.00253	0.00253	CcSEcCtD
Plerixafor—Dyspepsia—Methotrexate—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Plerixafor—Vomiting—Dexamethasone—psoriatic arthritis	0.00251	0.00251	CcSEcCtD
Plerixafor—Vomiting—Betamethasone—psoriatic arthritis	0.00251	0.00251	CcSEcCtD
Plerixafor—Rash—Betamethasone—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Plerixafor—Rash—Dexamethasone—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Plerixafor—Dermatitis—Betamethasone—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Plerixafor—Dermatitis—Dexamethasone—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Plerixafor—Fatigue—Methotrexate—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Plerixafor—Headache—Dexamethasone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Plerixafor—Headache—Betamethasone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Plerixafor—Asthenia—Prednisone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Plerixafor—Pain—Methotrexate—psoriatic arthritis	0.00245	0.00245	CcSEcCtD
Plerixafor—Pruritus—Prednisone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Plerixafor—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Plerixafor—Diarrhoea—Prednisone—psoriatic arthritis	0.00235	0.00235	CcSEcCtD
Plerixafor—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00235	0.00235	CcSEcCtD
Plerixafor—Nausea—Betamethasone—psoriatic arthritis	0.00234	0.00234	CcSEcCtD
Plerixafor—Nausea—Dexamethasone—psoriatic arthritis	0.00234	0.00234	CcSEcCtD
Plerixafor—Urticaria—Methotrexate—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Plerixafor—Dizziness—Prednisone—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Plerixafor—Abdominal pain—Methotrexate—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Plerixafor—Vomiting—Prednisone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Plerixafor—Rash—Prednisone—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Plerixafor—Dermatitis—Prednisone—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Plerixafor—Headache—Prednisone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Plerixafor—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Plerixafor—Asthenia—Methotrexate—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Plerixafor—Nausea—Prednisone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Plerixafor—Pruritus—Methotrexate—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Plerixafor—Diarrhoea—Methotrexate—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Plerixafor—Dizziness—Methotrexate—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Plerixafor—Vomiting—Methotrexate—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Plerixafor—Rash—Methotrexate—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Plerixafor—Dermatitis—Methotrexate—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Plerixafor—Headache—Methotrexate—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Plerixafor—Nausea—Methotrexate—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
